Resectable hepatocellular carcinoma
Clinical trials for Resectable hepatocellular carcinoma explained in plain language.
Never miss a new study
Get alerted when new Resectable hepatocellular carcinoma trials appear
Sign up with your email to follow new studies for Resectable hepatocellular carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink liver tumors before surgery
Disease control Recruiting nowThis study tests whether giving two drugs (ateganosine and cadonilimab) before surgery can safely shrink liver tumors in people with resectable hepatocellular carcinoma. About 60 participants will receive either one or both drugs before their operation. The main goal is to see if…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Early phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Drug cocktail aims to stop liver cancer recurrence after surgery
Disease control Recruiting nowThis study tests whether combining two drugs, atezolizumab and bevacizumab, given before and after surgery can help prevent liver cancer from coming back. It enrolls adults with a type of liver cancer that can be surgically removed but has a high risk of recurrence. Participants …
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase 2 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC